Abstract:Objective:To analyze the clinical features of type 2 diabetic patients with insulin autoimmune syndrome after treatment with exogenous insulin.Methods:A total of 106 patients with type 2 diabetes diagnosed with exogenous insulin-related insulin autoimmune syndrome (EIAS) were included from September 2017 to March 2019 in the Department of Endocrinology, Zhongshan Hospital, Fudan University. The clinical data, physical examination, and laboratory examination results of patients were collected.Results:Of the 106 patients, 84 (79.24%) used premixed human insulin or premixed insulin analogs, and 18 patients (16.98%) presented recurrent hypoglycemia. The arginine stimulation test showed that the median value of the baseline insulin was 73.40 (23.07-146.75) μU/ml, and the median ratio of 4 minute insulin to 0 minute insulin was 1.27 (1.03-1.85), with the mean of the ratio 1.72±1.47. The ratio of baseline insulin (μU/ml) to C-peptide (ng/ml) was 44.60 (14.92-87.93), with an average of 81.92±130.93. Taking the two-fold upper limit of fasting insulin reference value (49.8 μU/ml) as the cut-off point, the subjects were divided into insulin accumulation group (baseline insulin≥49.8 μU/ml) and insulin non-accumulation group (baseline insulin <49.8 μU/ml). Among the 66 patients in the insulin accumulation group, 14 patients had hypoglycemia (21.21%) and 4 patients in the insulin non-accumulation group presented hypoglycemia (10%). The ratio of 4 minute insulin to baseline insulin, ratio of baseline insulin to C-peptide, blood glucose level standard deviation (SDBG) and maximum blood glucose fluctuation amplitude (LAGE) in the insulin accumulation group were significantly higher than those in the insulin non-accumulation group (all P<0.05). Among 66 patients in the insulin accumulation group, 36 patients changed the type of insulin preparafion (insulin treatment group), 30 patients were changed from insulin to oral hypoglycemic agents (oral medication group). After treatment, both SDBG and LAGE in the two groups were significantly lower than before treatment ( P<0.05). Conclusions:With the aggravation of exogenous insulin accumulation, the fluctuation of blood glucose and the proportion of hypoglycemia were significantly increased. There was a characteristic change in islet function in patients with insulin autoimmune syndrome. After arginine stimulation, there was no significant peak of insulin secretion, showing a " high-level" curve. The baseline insulin/C-peptide ratio was significantly increased. The prognosis of EIAS patients is good after timely diagnosis and adjustment of treatment.

One case of insulin autoimmune syndrome

Clinical observation and nursing care on patients with type 2 diabetes applied as continuous subcutaneous insulin infusion

One case of Graves' disease with hypoglycemic coma

Clinical Characteristics of 109 Children with Newly Diagnosed as Type 1 Diabetes Mellitus

Investigation of TCM symptoms and syndrome in 180 patients with T2DM

Analysis on clinical features of 106 type 2 diabetic patients complicated with insulin autoimmune syndrome

One case of lipoatrophic diabetes mellitus with liver intumesce as initial symptom

Preliminary Investigation on Diagnostic Value of Polyethylene Glycol Precipitation and Gel Filtration Chromatography in Insulin Autoimmune Syndrome

Insulin autoimmune syndrome in an occidental woman: a case report and literature review

Exogenous insulin autoimmune syndrome: A case report and review of literature

[One Case of Severe Subcutaneous Soft Tissue Infection Caused by Nonstandard Insulin Injection].

The Influence Research of Inducing Immune Reaction of the Patients with Insulin Resistance to Sicca Syndrome

Neuropsychiatric profiles of patients with insulinomas.

Hypersomnia As the First Presentation in A Patient with Insulinoma: A Case Report and Review of the Literature

Insulin Autoimmune Syndrome: A Case Report Highlighting Diagnostic Pitfalls

A case report of fulminant type 1 diabetes mellitus associated with drug-induced hypersensitivity syndrome in an elderly patient with coxsackie B4 virus infection and human leukocyte antigen-A24 haplotype.

Long-term Follow-Up after Discharge Witnesses a Slow Decline of Insulin Autoantibodies in Patients with Insulin Autoimmune Syndrome Complicated with Grave's Disease: a Report of Two Cases.

Gliclazide - Induced Insulin Autoimmune Syndrome: A Rare Case Report and Review on Literature.

The eightieth case: young women, sitting and standing intolerance with vomiting after eating and body sweating for two months

Characteristics of Epidemic and Serum Lipid in Childhood Type 1 Diabetes Mellitus Diagnosed from 1999 to 2004 in Zhejiang Province

One Case of Multiple System Atrophy with the Syndrome of Inappropriate Antidiuresis